BioHarvest Sciences Inc. Common Stock (BHST) Financial Analysis & Valuation | Quarter Chart
BioHarvest Sciences Inc. Common Stock (BHST)
BHSTPrice: $4.28
Fair Value: 🔒
🔒score
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technol... more
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceut... more
Description
Shares
| Market Cap | $74.16M | Exchange | NASDAQ |
| Sector | Basic Materials | Industry | Agricultural Inputs |
| Country | CA | CEO | Ilan Sobel |
| IPO Date | 2021-01-08 | CAGR | — |
| Employees | 87 | Website | www.bioharvest.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
BHST chart loading...
Fundamentals
Technicals
| Enterprise Value | $81.51M | P/E Ratio | -10.33 |
| Forward P/E | -56.13 | PEG Ratio | — |
| P/S Ratio | 2.15 | P/B Ratio | 2.92 |
| P/CF Ratio | -10.18 | P/FCF Ratio | -7.66 |
| EPS | $-0.69 | EPS Growth 1Y | -40% |
| EPS Growth 3Y | -52.54% | EPS Growth 5Y | -28.08% |
| Revenue Growth 1Y | 37% | Gross Margin | 0.59% |
| Operating Margin | -0.16% | Profit Margin | -0.32% |
| ROE | -1.59% | ROA | -0.23% |
| ROCE | -0.14% | Current Ratio | 3.97 |
| Quick Ratio | 3.38 | Cash Ratio | 3 |
| Debt/Equity | 0.55 | Interest Coverage | -2.05 |
| Altman Z Score | -0.43 | Piotroski Score | 4 |
View BioHarvest Sciences Inc. Common Stock financial charts →